Roy Mugera

A man who believed he was suffering from a bad back after working in a pub and took paracetamol to manage the pain has tragically passed away at the age of 32. Roy Mugera, from Dagenham, died in the early hours of Wednesday, July 8.

 

Back in 2023, Roy was employed as a barman when he started experiencing back pain, which he attributed to carrying crates of stock and changing beer kegs in the cellar. The pain was so severe that he was forced to sleep in his gaming chair, on the living room sofa, or propped up across his bed in a seated position, using his desk chair as a leg rest, surrounded by pillows and a gym bag stuffed with clothes for additional support on his back and left side.

 

A lump on his side was visibly rising and falling.

 

At the time, Roy said: "At first, I didn't take the pain seriously because at the time, I was working as a bartender and with handling deliveries and restocking merchandise, I was constantly carrying heavy things. But over the next few months, as the pain worsened, I was in and out of hospital, trying to find solutions or to have a scan done for my back to see what was going on.

 

 

"I went to the GP several times as I was also starting to see a lump growing on my left diaphragm. It was painful, and I was also having cramps and stomaches. Before visiting the GP and being admitted to AandE, I had been taking over-the-counter painkillers like Paracetamol and Panadol, but they weren't helping," reports the Mirror.

It took almost five months, and three visits to his GP, before a biopsy uncovered the cause — synovial sarcoma, an exceptionally rare cancer with fewer than 80 diagnoses in England each year. He was devastated to learn his condition was incurable.

 

Chemotherapy proved so gruelling that Roy was forced to stop after just three of his six planned sessions. He survived two life-threatening bouts of sepsis, at one point coming within two hours of losing his life.

 

Radiotherapy in March 2024 offered a brief glimmer of hope, reducing his tumour from 22cm to just 1cm, but two nodules were subsequently discovered in his right lung, necessitating further surgery. By the time of his passing, his tumour had grown back to 17cm, and the cancer had returned to his lungs.

Roy spoke openly about the profound loneliness of being diagnosed with a rare cancer. "When I first heard the word sarcoma, I felt very alone," he said.

"Who else has sarcoma? I went on YouTube, where was my tribe?".

He discovered that community through Sarcoma UK, and went on to become one of its most compelling advocates, sharing his story so that others facing the same diagnosis would never feel as isolated as he once had. He shared a close bond with fellow synovial sarcoma patient Darrell McDonald, a father of two who passed away aged 44 earlier last year.

"I only knew Darrell for a brief time, but I was heartbroken," Roy said at the time.

 

Sarcoma UK is presently financing two research initiatives into synovial sarcoma, work that Roy's own campaigning helped bring into focus. At Imperial College London, scientists are creating a targeted treatment designed to attack only sarcoma cancer cells while leaving healthy tissue unharmed.

At the University of Edinburgh, scientists are examining the genetic abnormalities that drive sarcoma growth, with the goal of discovering treatments that could benefit multiple forms of the disease. Both initiatives are supported by the charity's Synovial Sarcoma Fund.

Sarcoma UK's Digital Communications Manager, Enda Guinan, said: "Roy wanted people affected by sarcoma to know they were not alone. He said that Sarcoma UK helped him 'find his tribe', and in turn he became part of that tribe for countless others.

 

 

"Even when he was very unwell, Roy was determined to use his own experience to help people who would never meet him. We are deeply grateful that he trusted us with his story, and to his family for supporting its continued sharing. Roy's voice will continue to reach people, and his contribution to the sarcoma community will not be forgotten."

Enjoyed this article? Stay informed by joining our newsletter!

Comments

You must be logged in to post a comment.

About Author